Adverse Drug Reaction Classification System

         

Pharmaceutical Information
Drug Name Prednisolone sodium phosphate
Drug ID BADD_D01833
Description Prednisolone phosphate is a glucocorticoid similar to [cortisol] used for its anti-inflammatory, immunosuppressive, anti-neoplastic, and vasoconstrictive effects.[A187463] Prednisolone phosphate was granted FDA Approval on 19 December 1973.[L14144]
Indications and Usage Prednisolone phosphate is indication to a number of conditions including treat allergic states, dermatologic diseases, edematous states, endocrine disorders, gastrointestinal diseases, hematologic disorders, neoplastic diseases, nervous system, ophthalmic diseases, respiratory diseases, rheumatic disorders.[L9437,L9440]
Marketing Status approved; vet_approved
ATC Code Not Available
DrugBank ID DB14631
KEGG ID D00981
MeSH ID C009022
PubChem ID 441409
TTD Drug ID Not Available
NDC Product Code 38779-0153; 51927-0050; 52128-164; 42799-812; 42799-813; 59212-700; 62135-330; 22552-0051; 64958-0042; 66993-845; 24002-0007; 0121-0773; 59212-702; 63187-215; 66993-844; 69238-2122; 24208-715; 0121-0777; 67296-1505; 68791-104; 49452-5996; 42799-815; 71052-610; 13925-166; 65089-0007; 42799-816; 59212-701; 62991-1205; 44523-182; 66993-846; 68788-7708; 22552-0004; 0121-0759; 0121-0902
UNII IV021NXA9J
Synonyms prednisolone phosphate | Predsol | prednisolone sodium phosphate | prednisolone phosphate, sodium salt, (11beta)-isomer | prednisolone 21-phosphate sodium | prednisolone phosphate sodium | prednisolone phosphate, monosodium salt, (11beta)-isomer | prednisolone-21-phosphate | Pediapred
Chemical Information
Molecular Formula C21H27Na2O8P
CAS Registry Number 125-02-0
SMILES CC12CC(C3C(C1CCC2(C(=O)COP(=O)([O-])[O-])O)CCC4=CC(=O)C=CC34C)O.[Na+].[Na+]
Chemical Structure
ADRs Induced by Drug
*The priority for ADR severity classification is based on FAERS assessment, followed by the most severe level in CTCAE rating. If neither is available, it will be displayed as 'Not available'.
**The 'Not Available' level is hidden by default and can be restored by clicking on the legend twice..
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Abdominal distension07.01.04.001--
Adrenal insufficiency14.11.01.004; 05.01.02.001--
Adrenocortical insufficiency acute14.11.01.020; 05.01.02.005--Not Available
Agitation17.02.05.012; 19.06.02.001--
Alkalosis hypokalaemic14.01.02.002--Not Available
Anaphylactic shock24.06.02.004; 10.01.07.002--Not Available
Angioedema22.04.02.008; 23.04.01.001; 10.01.05.009--Not Available
Anxiety19.06.02.002--
Arrhythmia02.03.02.001--Not Available
Arthralgia15.01.02.001--
Asthenia08.01.01.001--Not Available
Blindness06.02.10.003; 17.17.01.003--Not Available
Blood triglycerides increased13.12.03.001--Not Available
Body temperature increased13.15.01.001--Not Available
Carbohydrate tolerance decreased13.02.02.003--Not Available
Cardiac arrest02.03.04.001--
Cardiac failure congestive02.05.01.002--Not Available
Cataract subcapsular06.06.01.002--Not Available
Constipation07.02.02.001--
Cushing's syndrome05.01.01.001; 24.08.04.001; 19.07.03.002; 14.11.01.007--Not Available
Cushingoid19.07.03.001; 14.11.01.006; 05.01.01.002; 24.08.02.004--
Delusion19.10.01.001--
Dermatitis23.03.04.002--Not Available
Dermatitis acneiform23.02.01.004--
Dermatitis atopic23.03.04.016; 10.01.04.004--Not Available
Diabetes mellitus14.06.01.001; 05.06.01.001--Not Available
Diarrhoea07.02.01.001--
Discomfort08.01.08.003--Not Available
Dizziness02.11.04.006; 24.06.02.007; 17.02.05.003--
Drug withdrawal syndrome08.06.02.004; 19.07.06.013--Not Available
The 1th Page    1 2 3 4 5    Next   Last    Total 5 Pages